Sept 28 (Reuters) - Eli Lilly and Co said on Tuesday
it would lower the list price of its Insulin Lispro Injection in
the United States by an additional 40% from next year, bringing
it down to $82.41 for individual vials and $159.12 for a pack of
The list price for drugs is not necessarily what patients
actually pay, as out-of-pocket costs vary based on the duration
of the treatment and individual healthcare plans.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by